The neuronal nicotinic α4β2 receptor has a high maximal probability of being open
- 21 July 2010
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (8), 1906-1915
- https://doi.org/10.1111/j.1476-5381.2010.00761.x
Abstract
A fundamental property of transmitter-gated ion channels is the probability a channel will be open (P(open)) when stimulated by a concentration of agonist that elicits a maximal response. This value is critical for interpreting steady-state concentration-response relationships in terms of channel activation, and for understanding the actions of drugs that potentiate responses. We used analysis of non-stationary noise to estimate the maximal probability the nicotinic alpha4beta2 receptor is open. HEK293 cells stably transfected to express human alpha4beta2 nicotinic receptors were studied using whole-cell voltage clamp. Nicotinic agonists (acetylcholine, nicotine, cytisine and 5-iodo A-85380) were applied, and the relationship between variance of the elicited whole-cell current and mean current was analysed. The variance did not increase linearly with the mean current. For acetylcholine and nicotine the relationship between variance and mean indicates that the maximal P(open) is greater than 0.8. The number of agonist-activatable channels was estimated to be about 1000 per cell. The mean single channel conductance at -60 mV was indistinguishable when currents were elicited by acetylcholine (18 pS), nicotine (17 pS) or 5-iodo A-85380 (17 pS), whereas the value for cytisine was larger (24 pS). The neuronal nicotinic alpha4beta2 receptor has a maximal probability of being open that is greater than 0.8. This conclusion applies to the receptor containing three alpha4 and two beta2 subunits (the low-sensitivity stoichiometry), but may not apply to the receptor containing two alpha4 and three beta2 subunits (the high-sensitivity stoichiometry).Keywords
This publication has 41 references indexed in Scilit:
- Emerging drugs for the treatment of tobacco dependenceEmerging Drugs, 2009
- Cytisine-Based Nicotinic Partial Agonists as Novel Antidepressant CompoundsThe Journal of pharmacology and experimental therapeutics, 2009
- Mammalian Nicotinic Acetylcholine Receptors: From Structure to FunctionPhysiological Reviews, 2009
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Brain nicotinic acetylcholine receptors: native subtypes and their relevanceTrends in Pharmacological Sciences, 2006
- A‐85380: A Pharmacological Probe for the Preclinical and Clinical Investigation of the α4β2 Neuronal Nicotinic Acetylcholine ReceptorCNS Drug Reviews, 2006
- Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human α4β2 Acetylcholine ReceptorsMolecular Pharmacology, 2005
- First and Second Transmembrane Segments of α3, α4, β2, and β4 Nicotinic Acetylcholine Receptor Subunits Influence the Efficacy and Potency of NicotineMolecular Pharmacology, 2002
- Block by acetylcholine of mouse muscle nicotinic receptors, stably expressed in fibroblasts.The Journal of general physiology, 1995
- Single-channel currents of rat neuronal nicotinic acetylcholine receptors expressed in xenopus oocytesNeuron, 1989